Neonode Inc. (NEON) is a micro-cap IP licensing company with a balance sheet that, under the liquidation lens, shows positive but thin recovery to equity as of December 31, 2025. Total assets of $26.9M are dominated by cash and cash equivalents of $25.4M, which recovers at par. Accounts receivable of $0.4M (net, with zero allowance) recovers at ~90-95%, yielding roughly $0.37-0.38M. PP&E net of $0.15M and ROU assets of $0.51M (operating $0.46M, finance $0.05M) receive 0% and 0% recovery respectively under the lens—ROU assets extinguish on wind-up without value, and the PP&E gross of $0.42M less $0.27M accumulated depreciation leaves minimal tangible asset. Total tangible liquidation asset pool approximates $25.8-25.9M. Total liabilities at face value are $2.2M, of which current liabilities are $2.18M (AP $0.46M, accrued liabilities $0.46M, employee-related $0.87M, deferred revenue $0.04M, current operating lease $0.34M, current finance lease $0.01M) and non-current is $15K (finance lease). Operating lease commitments of $354K undiscounted (all due 2026) plus finance lease of $28K undiscounted remain obligations on wind-up at face. Net recovery to equity approximates $23.5-23.7M, consistent with MFFAIS-reported CLV/LLV/OLV of approximately $23.2-23.6M. Versus the prior filing (10-Q period ended September 30, 2025), the key change is a significant increase in cash driven by the October 2025 receipt of patent settlement proceeds from the Aequitas/Samsung litigation (disclosed in the prior 10-Q as a $19.4M gross gain with $3.8M broker fee, cash received post-period). As of 12/31/2025 the cash balance rose to $25.4M from $16.4M at 12/31/2024, primarily reflecting this inflow net of ongoing operating cash burn (~$10.3M used in operating activities for FY2025) and patent proceeds. The company carries $20.3M in gross deferred tax assets (NOL carryforwards: federal $73.2M, state $18.7M, foreign $17.5M) fully offset by a $20.2M valuation allowance; these have zero liquidation value. Disclosed material weaknesses in ITGC and income tax calculation controls are noted but do not alter the balance-sheet recovery posture directly. No debt instruments, no pension obligations, no goodwill or indefinite-lived intangibles on the balance sheet. The filing does not separately disclose a patent settlement receivable or contingent asset related to the ongoing Apple litigation (U.S. Patent No. 8,095,879) in XBRL; this is referenced in the prior 10-Q narrative only and absent from TAG_CONTEXT.
▼ Community Notes